Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes.
Sobha SivaprasadFaruque D GhanchiSimon P KellyAjay KotagiriJames TalksPeter Henry ScanlonHellen McGoeyAndrew NolanMoneeb SaddiqJackie NapierPublished in: Eye (London, England) (2023)
Year 2 results indicate that IVT-AFL is an effective treatment for DMO in real-world UK clinical practice, despite relatively low injection numbers. The high baseline visual acuity and QoL scores were maintained and there was further improvement in anatomical outcomes.